COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

ChulaCov19 mRNA Vaccine in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04566276
Recruitment Status : Not yet recruiting
First Posted : September 28, 2020
Last Update Posted : October 6, 2020
Center of Excellence in Vaccine Research and Development, Chulalongkorn University
Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University
Chula Vaccine Research Center (ChulaVRC), Faculty of Medicine, Chulalongkorn University
National Vaccine Institute (NVI), Thailand
National Research Council of Thailand
C2F Chulalongkorn University, Faculty of Medicine, Chulalongkorn University
Information provided by (Responsible Party):
Chulalongkorn University

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : June 2021